| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.08 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.08 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.08 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.095 | 0.08 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |